Our History

Orphazyme was founded in 2009 and listed at Nasdaq Copenhagen in 2017. The company focused on research and development of novel therapeutics for neurodegenerative diseases, such as Niemann Pick disease type C (NPC).

In May 2022, substantially all assets and business activities, including those relating to the development and approval of arimoclomol, were sold to KemPharm Denmark A/S (Zevra A/S).

The Company’s objects are to engage in activities and investments related to biopharmaceutical research and development as well as to carry out any associated activities as deemed relevant by the Board of Directors. Furthermore, the Company may, within its line of business, participate in partnerships or co-operate with other businesses.

In February 2024 the company invested in Combigene A/S, a Swedish listed company with research in gentherapy.

The company is owed by approximately 1900 shareholders.

Leadership Team
JB billede

Jakob Bendtsen

Chief Executive Officer

  • Joined in 2023
  • Educational background: MSc in Business Administration and Auditing
  • Competences: in-depth knowledge of M&A, accounting, tax and other finance matters.
  • Previously at Deloitte, Nets, Rockwool, Falck & William Demant
Board of Directors
MH billede 1

Michael Hove

Chairman

  • Member since: 2023
  • Born 1971, Danish nationality
  • Holds a bachelor in economic from 1995 from Copenhagen Business School.
  • Competences: Strategy, sales, financial, capitalstructure and M&A
  • Chairman/CEO/owner at Rovsing, Scandinavian Investment Group, Hydract, MH Investment, Antique 89, and Symmetry Administration.
JB billede v2

Jakob Bendtsen

Board Member

  • Joined in 2023
  • Educational background: MSc in Business Administration and Auditing
  • Competences: in-depth knowledge of M&A, accounting, tax and other finance matters.
  • Previously at Deloitte, Nets, Rockwool, Falck & William Demant
JH billede

Jakob Have

Board Member

  • Member since: 2023
  • Born 1981, Danish nationality
  • MSc in Business Administration and Auditing from Copenhagen Business School.
  • Competences: Auditing, Taz, compliance and M&A
  • Founder/boardmember: Nordic Compound A/S, Scandinavian Medical Services & Scandinavian Investment Group